BioStem Technologies, Inc. (BSEM)

BioStem Technologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	6.96	29.55	22.83	0.24	0.77	0.34
Cash & Short-Term Investments	6.96	29.55	22.83	0.24	0.77	0.34
Cash Growth	-77.43%	29.42%	9437.23%	-68.99%	126.88%	559.83%
Accounts Receivable	6.62	9.87	23.11	11.37	0.04	0.3
Receivables	6.62	9.87	24.36	11.37	0.04	0.3
Inventory	4.71	2.88	1.82	0.66	0.4	0.26
Prepaid Expenses	2.49	2.1	2.87	0.33	0.28	0.04
Total Current Assets	20.78	44.4	51.89	12.6	1.49	0.94
Property, Plant & Equipment	5.15	5.26	1.97	1.37	1.37	1.28
Goodwill	1.53	0.24	0.24	0.24	0.24	0.24
Other Intangible Assets	21.36	0.12	0.22	0.35	0.36	0.21
Long-Term Deferred Tax Assets	-	-	3.99	-	-	-
Total Assets	48.82	50.03	58.32	14.56	3.47	2.67

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	5.64	1.4	2.16	1.39	0.05	0.65
Accrued Expenses	4.27	6	8.1	9.48	2	2.47
Short-Term Debt	1	3	3	3.05	3.72	-
Current Portion of Long-Term Debt	-	-	0.96	1.4	0.32	3
Current Portion of Leases	0.22	0.23	0.11	0.04	0.08	0.09
Current Income Taxes Payable	-	0.03	3.5	-	-	-
Current Unearned Revenue	-	-	-	-	-	0.07
Other Current Liabilities	10.08	0.13	0.14	0.25	0.16	0.27
Total Current Liabilities	21.2	10.78	17.97	15.62	6.33	6.54
Long-Term Debt	-	-	0.15	0.27	1.03	1.8
Long-Term Leases	0	0.11	0.18	0.02	0.06	0.01
Other Long-Term Liabilities	-	-	-	-	-	0.12
Total Liabilities	21.2	10.89	18.3	15.9	7.42	8.47

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.02	0.02	0.02	0.02	0.01	0.01
Additional Paid-In Capital	66.61	60.34	54.64	44.31	33.1	24.02
Retained Earnings	-38.97	-21.17	-14.59	-45.62	-37.14	-29.95
Treasury Stock	-0.04	-0.04	-0.04	-0.04	-0.04	-0.04
Total Common Equity	27.61	39.14	40.02	-1.34	-4.08	-5.96
Minority Interest	-	-	-	-	0.13	0.17
Shareholders' Equity	27.61	39.14	40.02	-1.34	-3.95	-5.79
Total Liabilities & Equity	48.82	50.03	58.32	14.56	3.47	2.67

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1.22	3.33	4.39	4.77	5.21	4.89
Net Cash (Debt)	5.74	26.22	18.44	-4.53	-4.44	-4.55
Net Cash Growth	-78.94%	42.20%	-	-	-	-
Net Cash Per Share	0.34	1.57	0.85	-0.33	-0.39	-0.39
Filing Date Shares Outstanding	17.85	16.98	16.64	16.34	12.16	18.98
Total Common Shares Outstanding	17.82	16.81	16.64	16.2	12.16	18.98
Working Capital	-0.42	33.62	33.92	-3.02	-4.84	-5.6
Book Value Per Share	1.55	2.33	2.40	-0.08	-0.34	-0.31
Tangible Book Value	4.72	38.77	39.55	-1.94	-4.68	-6.41
Tangible Book Value Per Share	0.27	2.31	2.38	-0.12	-0.39	-0.34
Land	2.37	2.37	0.08	0.08	0.08	0.08
Buildings	1.77	1.26	1.23	1.13	1.12	1.11
Machinery	1.65	1.65	1.39	1.06	1.06	0.93
Construction In Progress	0.51	0.96	0.19	0.2	0.1	-

Data Source: S&P Global Market Intelligence Last updated: May 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 18, 2026

Data Sources Report a data error